Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-005839
Filing Date
2017-08-03
Accepted
2017-08-03 16:07:43
Documents
72
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bivv-20170630x10q.htm 10-Q 1966701
2 EX-31.1 bivv-20170630ex311bd3c45.htm EX-31.1 12507
3 EX-31.2 bivv-20170630ex3124b84bf.htm EX-31.2 12855
4 EX-32.1 bivv-20170630ex3213f3357.htm EX-32.1 15047
5 GRAPHIC bivv20170630x10q001.jpg GRAPHIC 16846
6 GRAPHIC bivv20170630x10q002.jpg GRAPHIC 22480
7 GRAPHIC bivv20170630x10q003.jpg GRAPHIC 22128
8 GRAPHIC bivv20170630x10q004.jpg GRAPHIC 22079
9 GRAPHIC bivv20170630x10q005.jpg GRAPHIC 22334
  Complete submission text file 0001558370-17-005839.txt   7306464

Data Files

Seq Description Document Type Size
10 EX-101.INS bivv-20170630.xml EX-101.INS 1561980
11 EX-101.SCH bivv-20170630.xsd EX-101.SCH 45288
12 EX-101.CAL bivv-20170630_cal.xml EX-101.CAL 70142
13 EX-101.DEF bivv-20170630_def.xml EX-101.DEF 155106
14 EX-101.LAB bivv-20170630_lab.xml EX-101.LAB 450994
15 EX-101.PRE bivv-20170630_pre.xml EX-101.PRE 316270
Mailing Address 225 2ND AVENUE WALTHAM MA 02451
Business Address 225 2ND AVENUE WALTHAM MA 02451 781-663-4400
Bioverativ Inc. (Filer) CIK: 0001681689 (see all company filings)

EIN.: 813461310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37859 | Film No.: 171004931
SIC: 2834 Pharmaceutical Preparations